| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Hamon Center for Therapeutic Oncology Research and Departments of 2 Internal Medicine, 3 Pharmacology, 4 Pathology, 5 Cell Biology, and 6 Cardiovascular and Thoracic Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas; 7 Dallas Veterans Affairs Medical Center, Dallas, Texas; 8 Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 9 Department of Pathology, Stanford University Medical Center, Stanford, California
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The telomere hypothesis postulates that progressive shortening of the ends of chromosomes (telomeres) in the absence of telomerase or other compensating mechanisms is the mitotic clock that regulates the onset of replicative senescence in normal somatic cells (4, 5, 6) . The model of mortality stages (M1 and M2) limiting the replicative capacity of normal somatic cells was first described in fibroblasts (7 , 8) . Since then, numerous attempts to verify a similar pattern of growth and checkpoint arrest for epithelial cells have been pursued. However, it was found that most epithelial cells propagating in standard culture conditions [e.g., cells cultured in chemically defined medium, without feeder layers, and under normoxia (20% O2)] undergo growth arrest early in their life span, well before telomeres become short enough to elicit a telomere-dependent response. This premature growth arrest cannot be explained in terms of telomere shortening. We reported previously that premature growth arrest in epidermal keratinocytes and human mammary epithelial cells when cultivated in vitro was associated with up-regulation of the cyclin-dependent kinase (Cdk) inhibitor, p16INK4a (9 , 10) . We found that by overexpressing Cdk4, the p16INK4a-associated premature growth arrest was prevented, whereas expression of hTERT bypassed telomere-dependent senescence (M1), resulting in immortal cell lines (10 , 11) . In the current study, we have used this same strategy to generate immortal HBEC lines from small bronchial biopsies obtained during routine patient care. Ectopic Cdk4 was introduced to eliminate the stress response of the bronchial epithelial cells to the in vitro culture conditions, followed by introduction of hTERT to prevent further telomere shortening. We have found that this method reproducibly generates immortalized cells from the bronchial epithelium that have few genetic alterations, do not have a malignant phenotype, and are distinct from immortalized cultures developed by viral oncoproteins. These cultures are important new reagents for understanding the pathogenesis of lung cancer.
| MATERIALS AND METHODS |
|---|
|
|
|---|
0.5 cm3) from areas of the lung histologically not involved with lung cancer were obtained from donors (after obtaining informed consent on institutional review board-approved protocols) undergoing surgical resection for lung and other cancers and transported from the surgical suite to the laboratory in Hanks balanced salt solution (Gelasco, NY) with 0.4% (v/v) of an antibiotic/antimycotic solution [penicillin (10,000 IU/mL), streptomycin (10,000 mg/mL), and amphotericin B (5,000 IU/mL); Gibco, Gaithersburg, MD]. Tissue was dissected and minced into
4-mm pieces and plated on porcine collagen I (Sigma, St. Louis, MO)-coated tissue culture dishes containing K-SFM media (Invitrogen, Carlsbad, CA). Primary cultures were left undisturbed for 21 days in Modular Incubator Chambers (Billups-Rothenberg, Del Mar, CA) under low oxygen environment (23% O2) and 5% CO2 (the low oxygen concentration helped lower p16INK4a levels), with changes of media once every 5 days for the first week, and then every other day. When epithelial cell outgrowths were noticeable, we subcultured at a 1:4 ratio with the K-SFM medium, providing a selection against fibroblast and other stromal cell growth (due to the lack of fibroblast growth factors in this medium). Cdk4 was introduced by a retroviral construct (pSR
MSU, G418+) into the cultures at population doubling (PD)
320 with G418 selection, followed by introduction of another retroviral construct (pBABE-hTERT, puromycin+) at PD
1037 as described previously (11)
. Human papilloma virus (HPV)-16 E6/E7 was introduced by a retroviral construct (pLXSN, G418+) into uninfected cultures at PD 12 with G418 selection. After selection, cells infected with either Cdk4 + hTERT or HPV-16 E6/E7 were serially passaged until they underwent a growth arrest or became immortalized (immortal cell line was defined as >100 PDs). Cells could be switched to normoxic conditions after introduction of Cdk4 without decline in growth rate or life span. However, we kept the culture of HBECs in collagen-coated dishes to facilitate attachment.
PD was calculated as follows: outgrowths were trypsinized, resuspended as a single cell suspension, and counted (Coulter Cell and Particle Counter, Z1 Single Threshold Model; Beckman Coulter, Hialeah, FL). After counting the cells, the initial primary cultures were reseeded and considered to be at PD = 0. Unattached cells were collected and counted the next day to determine the number of remaining attached cells on the primary culture. Because the attachment efficiency was >98%, the number of unattached cells was disregarded in calculating subsequent PDs. Gained PD was calculated at each passage by using the following equation: n = log(NH/NI)/log2, where n is the number of PDs, NH is the number of cells harvested at the end of the growth period, and NI is the number of cells inoculated. Gained PDs were added at each passage to compute the cumulative PD depicted in the growth curve figures (Fig. 1AE)
.
|
MSU (G418+) expressing mouse Cdk4 was developed from the generous gift of Charles J. Sherr (St. Jude Childrens Research Hospital, Memphis, TN). This is the same construct used previously (11)
. HBECs were infected with medium containing Cdk4wt helper-free viral supernatant produced from pSR
MSU (G418+) expressing the Cdk4 vector in the presence of 4 µg/mL Polybrene (Sigma) for 10 to 12 hours. Cells were allowed to recover for 72 hours followed by drug selection with 30 µg/mL G418 (Calbiochem, San Diego, CA) for 10 days. Bronchial cells were then infected with a second retroviral construct, pBABE (puromycin+) expressing hTERT. This is the same construct used previously (10
, 11)
. Bronchial cells were infected with conditioned media containing hTERT helper-free viral supernatant [produced by pBABE (puromycin+)] in the presence of 4 µg/mL Polybrene followed by selection with 250 ng/mL puromycin (Sigma) for 3 to 4 days, initiated 72 hours later. Retroviral parent vector pLXSN was obtained from A. D. Miller (Seattle, WA). The HPV-16 E6/E7 genes were cloned into a vector under transcriptional regulation of the Moloney murine leukemia virus promoter-enhancer sequences [obtained from D. A. Galloway (Seattle, WA)]. These retroviral vectors also contain the gene conferring neomycin resistance under transcriptional regulation of the SV40 promoter. Plasmid DNA was transfected into the ecotropic packaging cell line PE501 by calcium phosphate precipitation and selected with G418 (1 µg/mL). Derived viral supernatant was used to infect the amphotrophic packaging cell line PA317 (12)
to generate clones containing unrearranged proviral copies of pLXSN parental vector and pLXSN vector containing HPV-16 E6/E7. PA317 clones were selected on G418 (1 µg/mL). Medium containing released viruses produced from confluent dishes was filtered (pore size, 0.45 mm) and used to infect parental HBEC2 and HBEC3 cells in the presence of 4 µg/mL Polybrene (Sigma) for 10 to 12 hours. Bronchial cells were allowed to recover for 72 hours followed by drug selection with 30 µg/mL G418 (Calbiochem) for 10 days.
Telomeric Repeat Amplification Protocol.
After harvesting of cells from culture, 105 cells were aliquoted into a DNase-free, RNase-free 1.5-mL microfuge tube. This aliquot of cells was pelleted by centrifugation in a tabletop centrifuge (5415D; Eppendorf) at 6,000 rpm for 6 minutes at room temperature. The supernatant was aspirated and discarded, and the remaining cell pellet was snap frozen in liquid nitrogen and stored at 80°C until analysis by telomeric repeat amplification protocol (TRAP) assay (13, 14, 15)
. One thousand cells were used in a nonradioactive polymerase chain reaction (PCR)-based assay using the TRAPeze telomerase detection kit (Intergen, Purchase, NY). The reaction mixture was prepared using the TRAP buffer, deoxynucleoside triphosphate mix, and TRAP-primer mix (containing an anchored CX primer and the Internal Standard 32P primers) from Intergens kit. A modified TS primer (5'-Cy5-AATCCGTCGAGCAGAGTT; Integrated DNA Technologies, Inc.), 20 µg of ultrapure bovine serum albumin (Ambion, Austin, TX), and 2 units of Taq DNA polymerase were added to this mixture, and PCR cycles were performed as recommended (Intergen). After PCR, 20 µL of the TRAP reaction mixtures were separated on 10% nondenaturing acrylamide gels, and the gels were fixed in 0.5 mol/L NaCl, 50% EtOH, and 40 mmol/L sodium acetate (pH 4.2) for 30 minutes and exposed, without drying, to phosphor screens overnight and visualized on a PhosphorImager using ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
Ultraviolet Irradiation.
Ultraviolet (UV) irradiation was performed in a homemade box built with four UV-B bulbs (Philips Lighting). Applied UV-B dose was measured by radiometer (IL-1400A radiometer/photometer; International Light, Newburyport, MA). Infected and uninfected control cells were plated in duplicate at 5 x 105 cells per 100-mm culture dish containing growth medium and incubated overnight. After two rinses with 1x PBS, liquid was aspirated, and the cells were irradiated at different doses: 50, 100, 200, and 400 J/m2 UV-B. Growth medium was added to the cells immediately after irradiation, and cells were incubated for 24 hours. Untreated dishes from each cell line served as a control. After incubation, cells were harvested for protein extracts.
Immunoblotting.
Protein extracts prepared from logarithmically growing cells were lysed in 2% SDS in 50 mmol/L Tris-HCl, and total protein concentration was determined using the BCA assay (Pierce, Rockford, IL). Fifty micrograms of each sample were electrophoresed on a 12% and 15% SDS polyacrylamide gel and transferred to nitrocellulose (Amersham, Arlington Heights, IL), the nitrocellulose was blocked in 5% nonfat dry milk and incubated in primary antibody [p16INK4a (clone G175-1239; 2 mg/mL; PharMingen, San Diego, CA), p53 [Ab-6; 1 mg/mL; Oncogene Research Products, Boston, MA), p14ARF (Ab-1; 1 mg/mL; Oncogene Research Products); and actin (AC-40; 1:3,000; Sigma)] for 1 hour at room temperature. The membranes were washed with 1x PBS/0.1% Tween 20 and incubated with horseradish peroxidase-conjugated sheep antimouse IgG (Amersham) at a dilution of 1:3,000 when p16INK4a or actin was the primary antibody and a dilution of 1:5,000 when p53 and p14ARF were the primary antibodies, and specific protein bands were detected using a chemiluminescent substrate (SuperSignal Substrate; Pierce).
Karyotyping.
Cell lines were incubated with Colcemid (Invitrogen) for 2 hours and harvested with trypsin. Cells were then treated with hypotonic KCl solution (0.075 mol/L) for 30 minutes at 37°C, fixed and washed three times with methanol/acetic acid (3:1), resuspended, and dropped onto slides. GTG-banded chromosome preparations were made using standard methods. At least 20 cells were analyzed from each culture, and chromosome images were captured and analyzed.
DNA Extraction.
Genomic DNA was isolated from frozen cell pellets by homogenization, SDS/proteinase K (Life Technologies, Inc., Rockville, MD) digestion, phenol-chloroform extraction, and EtOH precipitation (16)
.
Expression and Comparative Genomic Hybridization Microarrays.
RNA fluorescent labeling reaction and hybridization were performed with 5 µg of RNA using the Affymetrix GeneChips HG-U133-Plus2 according to the manufacturers instructions.10
The array consists of 54,675 probe sets (29,180 unique genes). All array data are available on-line in a Minimum Information About a Microarray Experiment (MIAME) compliant database.11
Analysis was performed with Affymetrix MicroArray Suite 5.0 and with an in-house Visual Basic software MATRIX 1.25.12
This program imports multiple CHP files (saved as text files) from MicroArray Suite 5.0 into an Excel spreadsheet and performs various analyses including normalization, grouping and comparison of arrays using log ratios, scatter plots, color display, and hierarchical clustering. Comparative genomic hybridization (CGH) microarrays or array CGH (aCGH) microarrays were performed as described previously (17
, 18)
using 10 µg of genomic DNA. Analysis of aCGH data in Fig. 5
was done using Caryoscope software.13
Analysis of aCGH data provided in the supplemental figures was done using MATRIX, which sorts array data according to chromosome location [based on GoldenPath hg16;14
it calculates a 5-point moving average to reduce local variations and then generates a color display with red for DNA gain and green for DNA loss].
|
| RESULTS |
|---|
|
|
|---|
Premature Growth Arrest Associated with Normoxic Culture Conditions and Increased Expression of p16INK4a.
Culturing bronchial epithelial cells under normoxic (20%) conditions was associated with increased expression of p16INK4a compared with cultures in low oxygen levels (23% O2; Fig. 2
). Thus, we initially cultured parental bronchial cells in low oxygen conditions, under which they only experience normoxic conditions transiently during subculture and medium changes. However, even under these culture conditions, an increase in p16INK4a expression was detected at PD 1016, resulting in growth arrest (Fig. 2)
. This may be due to additional stresses such as chemically defined medium condition or growth in the absence of feeder layers. We reasoned that to further increase life span, a method of bypassing p16INK4a-induced growth arrest was needed. Thus, Cdk4 was exogenously overexpressed to bypass the p16INK4a-induced premature growth arrest, as reported previously for other epithelial cell types (11)
. Overexpression of Cdk4 extended the life span of HBECs (
PD 2432; Fig. 1AE
) and was associated with up-regulation of p16INK4a to very high levels (Fig. 3A)
, but not with up-regulation of p53 or p14ARF (Fig. 3B)
. This result suggests that pathways implicated in the up-regulation of p16INK4a during premature growth arrest may involve only the INK4a arm of the INK4a/Arf gene locus. In addition, as reported previously (11)
, elongation of life span of HBECs on introduction of Cdk4 did not reactivate or up-regulate endogenous telomerase in 12 separate culture (Fig. 3C)
, and thus Cdk4-expressing cells senesced (Figs. 1AE
and 4
). Thus, we introduced hTERT into Cdk4-expressing cells, which resulted in the introduction of unlimited proliferative capacity (Figs. 1AE
, 3B
, and 4
). In addition, after the combination of Cdk4 and hTERT was expressed in the HBECs, they could be switched to normoxic conditions without any sign of change in growth rate or life span.
|
|
|
In HBECs immortalized with HPV-16 E6/E7 (and strongly expressing telomerase either spontaneously or after introduction of a hTERT expression vector), there was a moderate increase of p16INK4a in cells before UV irradiation (compared with control), and there was no further increase on UV irradiation. In HBEC3 E6/E7 cells (in which telomerase expression is extremely weak and comes from an endogenous source), expression of p16INK4a was low before UV irradiation compared with control, and there was a significant increase on UV irradiation. By contrast, in HBEC3 E6/E7/hTERT cells (in which telomerase is strongly positive after introduction of an exogenous expression vector), there was no increase of p16INK4a on UV irradiation, mimicking the results detected in HBEC2 E6/E7 (strongly positive telomerase expression). This result suggests that expression of telomerase (and thus, maintenance of telomeric ends) may be involved in p16INK4a-dependent stress signaling mechanisms. In HBEC2 E6/E7 cells (in which telomerase is strongly expressed from an endogenous source), we detected that expression of p53 remained at the same level compared with control with or without UV irradiation (Fig. 3D)
. In HBEC3 E6/E7 (weakly positive telomerase expression) and HBEC3 E6/E7/hTERT (strongly positive telomerase expression) cell lines, expression of p53 was not detected before or after UV irradiation. These results suggest HPV-16 E6/E7 abrogates p53 regulation independent of the level of telomerase expression.
Gene Expression Profile, Array Comparative Genomic Hybridization Profile, and Karyotypic Analysis.
We next examined aCGH profiles of five HBEC lines including parental, Cdk4/hTERT-immortalized, and HPV-16 E6/E7-immortalized cell lines (Fig. 5A and B
; supplemental figures 18). We identified duplication of chromosome 5 and 20 regions in all immortalized cell lines (Cdk4/hTERT and HPV-16 E6/E7), but not in the parental preimmortalized cultures. In addition to duplication of chromosomes 5 and 20, HBEC2 HPV-16 E6/E7 cell line showed regional macrodeletions in chromosomes 6p and 20q (supplemental figures 18). In contrast to HBEC14, the HBEC5 Cdk4/hTERT (whose parental bronchial epithelial culture, NHBEC, was obtained from Clonetics) showed multiple regional amplifications and deletions in several chromosomes (supplemental figures 18). BEAS2B (T antigen-immortalized HBEC line) also showed multiple regional microamplifications and amplifications on chromosomes 5, 8q, 9, 16q, 17q, and 20q and multiple regional microdeletions and deletions on chromosomes 8p, 16p, and X. None of these karyotypic results appears to be related to smoking history.
Characterization of gene expression array data derived from Affymetrix U133-Plus2 chips showed that both Cdk4/hTERT-immortalized and HPV-16 E6/E7-immortalized cells had gene expression signatures that clustered together and were distinct from those of lung cancer cell lines (Fig. 6)
. However, within the HBEC cluster, different subgroups were formed by nonimmortalized, Cdk4/hTERT-immortalized, and HPV-16 E6/E7-immortalized bronchial epithelial cells (Fig. 6)
. Gene expression profiles of the Cdk4/hTERT-immortalized and parental cells were more similar than either was to HPV preimmortalized cells (Fig. 6
; see supplemental figure 9 for gene list). These results suggest that Cdk4/hTERT immortalization involved different changes in gene expression than HPV immortalization and that the gene expression profile of Cdk4/hTERT-immortalized cells is closer to that of the starting parental bronchial epithelial cells.
|
Human Bronchial Epithelial Cells Express Stem Cell Marker p63.
The HBECs were immunostained for p63, a p53 homolog essential for regenerative proliferation in epithelial development. All five HBEC lines expressed the stem-like cell marker p63 (Fig. 7)
, suggesting the immortalized cell lines had characteristics of pulmonary stem cells. In work to be reported elsewhere,15
we also know the Cdk4/hTERT-immortalized HBECs have the ability to differentiate in organotypic cultures to form cilia.
|
| DISCUSSION |
|---|
|
|
|---|
We observed that culture of HBECs in chemically defined medium, without feeder layers, and under ambient (21%) O2 conditions was associated with up-regulation of p16INK4a, leading to premature growth arrest of the cells (PD
23, passage 1; Fig. 2
). The role of the ambient (21%) and low oxygen (25%) on the ability to immortalize fetal and adult cells with hTERT has been assessed previously (23)
, as well as the consequences of culturing epithelial cells under inadequate conditions (9
, 10) . We reasoned that culturing primary bronchial epithelial cells in collagen-coated dishes and low oxygen conditions (25%) would help to keep p16INK4a expression, whereas overexpressing Cdk4 would bypass cell cycle checkpoints, thus allowing further extension of life span. Consistently, ectopic Cdk4-overexpressing cells showed a 2- to 3-fold prolonged life span compared with controls.
After extension of life span by Cdk4, direct immortalization was achieved by introduction of hTERT. To determine whether the cells became transformed on immortalization, we assessed their phenotype for malignant transformation and compared their gene expression profiles by microarray analysis. None of the immortalized bronchial cell lines formed colonies in soft agar or tumors in nude mice. Gene expression profiles showed immortalized bronchial cell lines clustered together with each other and with nonimmortalized bronchial cells, but the immortalized bronchial cell lines were distinct from lung cancer cell lines and viral oncoprotein-immortalized bronchial epithelial cells. Thus, immortalization of HBECs with Cdk4 and hTERT provides a method to generate cellular reagents, which are closer to their normal counterparts, thus making them new useful cellular reagents for studying the molecular pathogenesis of lung cancer. These studies include identification of molecular markers that precede disease, which are useful in early detection, and identification of novel therapeutic targets. Furthermore, comparisons of Cdk4/hTERT- immortalized cell lines and their control counterparts by aCGH revealed that these immortal cell lines were remarkably genomically stable, except for the duplication of chromosome 5 and 20. In contrast, the HPV-16 E6/E7-immortalized cells showed, in addition to duplication of chromosomes 5q and 20q, regional macrodeletions in chromosomes 6p and 20q. The duplication of chromosomes 5 and 20 in the immortal cell lines is intriguing. Low copy number gains of chromosomes 5 and 20 previously have been reported to be associated with cellular immortalization by viral oncoproteins (24, 25, 26, 27, 28) . In addition, two human mammary epithelial hTERT-immortalized cell lines have been found to be trisomic for chromosome 20 (29) . These results suggest that gain of one or more genes on these chromosomes might contribute to cellular immortalization. However, another explanation could be that chromosomal duplications are the result of mitotic nondisjunction due to integration of the proviral cDNA into the cells genome after retroviral transfection. Additional studies are required to determine whether in vitro manipulation also contributed to the chromosomal duplications.
In summary, we have established a general and practical approach to generate normal immortalized HBECs from clinically accessible specimens. These cultures provide models that can be genetically manipulated in a stepwise fashion to progress the cells toward malignancy that may be useful for studying the early stages of preneoplasia and progression, differentiation, and morphogenesis and for comparisons with lung cancer for the identification of new genetic and epigenetic differences between tumor and normal cells. These results suggest it should be possible to generate immortalized cultures representing several or all of the different steps in lung cancer pathogenesis. The ability to genetically manipulate these cells will allow us to systematically test the importance for the malignant phenotype of the many different changes found in lung cancer. Finally, HBECs with defined genetic changes may be useful for screening and testing new chemopreventive and therapeutic agents that would have specificity against proteins encoded by these changes.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Note: Supplementary data for this article can be found at Cancer Research Online (http://cancerres.aacrjournals.org). W. Wright and J. Shay are coholders of the Southland Financial Corporation Distinguished Chair in Geriatric Research.
Requests for reprints: John D. Minna, Hamon Center for Therapeutic Oncology Research NB8.206, The University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-8593. Phone: 214-648-4900; Fax: 214-648-4940; E-mail: John.Minna{at}UTSouthwestern.edu
11 http://microarray.swmed.edu/smcdb/swarray_db.html. ![]()
12 Girard, L. and Minna, J. D. Matrix, a microarray anlaysis tool in EXCEL, manuscript in preparation. ![]()
13 http://dahlia.stanford.edu:8080/caryoscope/index.html. ![]()
15 Vaughan, M. B., Ramirez, R., Sato, M., Sheridan, S., Milchgrub, S., Dimaio, J. M., Minna, J. D., and Shay, J. W. Differentiation of immortalized human bronchial epithelial cells in organotypic 3D cultures, manuscript in preparation. ![]()
Received 10/14/04. Accepted 11/ 8/04.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. A. Mebratu, B. F. Dickey, C. Evans, and Y. Tesfaigzi The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFN{gamma}-induced cell death J. Cell Biol., November 3, 2008; 183(3): 429 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Guha, R. Chaerkady, A. Marimuthu, A. S. Patterson, M. K. Kashyap, H. C. Harsha, M. Sato, J. S. Bader, A. E. Lash, J. D. Minna, et al. Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS PNAS, September 16, 2008; 105(37): 14112 - 14117. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shivapurkar, V. Stastny, N. Okumura, L. Girard, Y. Xie, C. Prinsen, F. B. Thunnissen, I. I. Wistuba, B. Czerniak, E. Frenkel, et al. Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene Cancer Res., September 15, 2008; 68(18): 7448 - 7456. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, H. Shigematsu, M. Nomura, W. W. Lockwood, M. Sato, N. Okumura, J. Soh, M. Suzuki, I. I. Wistuba, K. M. Fong, et al. PIK3CA Mutations and Copy Number Gains in Human Lung Cancers Cancer Res., September 1, 2008; 68(17): 6913 - 6921. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ye and R. Lotan Potential misinterpretation of data on differential gene expression in normal and malignant cells in vitro Brief Funct Genomic Proteomic, July 1, 2008; 7(4): 322 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Chapman, G. Kelly, and M. A. Knowles Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial Cells Mol. Cancer Res., July 1, 2008; 6(7): 1154 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kida, M. L. Mucenski, A. R. Thitoff, T. D. Le Cras, K.-S. Park, M. Ikegami, W. Muller, and J. A. Whitsett GP130-STAT3 Regulates Epithelial Cell Migration and Is Required for Repair of the Bronchiolar Epithelium Am. J. Pathol., June 1, 2008; 172(6): 1542 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shivapurkar, V. Stastny, Y. Xie, C. Prinsen, E. Frenkel, B. Czerniak, F. B. Thunnissen, J. D. Minna, and A. F. Gazdar Differential Methylation of a Short CpG-Rich Sequence within Exon 1 of TCF21 Gene: A Promising Cancer Biomarker Assay Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 995 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, M. Bhutani, A. K. Pathak, W. Lang, H. Ren, J. Jelinek, R. He, L. Shen, J.-P. Issa, and L. Mao {Delta}DNMT3B Variants Regulate DNA Methylation in a Promoter-Specific Manner Cancer Res., November 15, 2007; 67(22): 10647 - 10652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, S.-C. Yang, S. Sharma, J. Luo, X. Cui, K. A. Peebles, M. Huang, M. Sato, R. D. Ramirez, J. W. Shay, et al. EGFR Signaling Is Required for TGF-beta1 Mediated COX-2 Induction in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 578 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, X. Wang, J. Zhuang, L. Zhang, and Y. Lin Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells Carcinogenesis, October 1, 2007; 28(10): 2114 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Yazicioglu, D. L. Goad, A. Ranganathan, A. W. Whitehurst, E. J. Goldsmith, and M. H. Cobb Mutations in ERK2 Binding Sites Affect Nuclear Entry J. Biol. Chem., September 28, 2007; 282(39): 28759 - 28767. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Konishi, B. Karakas, A. M. Abukhdeir, J. Lauring, J. P. Gustin, J. P. Garay, Y. Konishi, E. Gallmeier, K. E. Bachman, and B. H. Park Knock-in of Mutant K-ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K-ras Mediated Transformation Cancer Res., September 15, 2007; 67(18): 8460 - 8467. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Gorlov, P. Meyer, T. Liloglou, J. Myles, M. B. Boettger, A. Cassidy, L. Girard, J. D. Minna, R. Fischer, S. Duffy, et al. Seizure 6-Like (SEZ6L) Gene and Risk for Lung Cancer Cancer Res., September 1, 2007; 67(17): 8406 - 8411. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Elayadi, K. N. Samli, L. Prudkin, Y.-H. Liu, A. Bian, X.-J. Xie, I. I. Wistuba, J. A. Roth, M. J. McGuire, and K. C. Brown A Peptide Selected by Biopanning Identifies the Integrin {alpha}v{beta}6 as a Prognostic Biomarker for Nonsmall Cell Lung Cancer Cancer Res., June 15, 2007; 67(12): 5889 - 5895. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Das, B. P. Chen, M. D. Story, M. Sato, J. D. Minna, D. J. Chen, and C. S. Nirodi Somatic Mutatio |